S100A9/12—another significant marker of CD52+ Mp reported here and by Alivernini et al.—has the potential to induce inflammation in fibroblast with the production of TNF-α and IL-6 and persist in remission RA, supporting our hypothesis above (10, 21). This evidence concerns the gene IL6 and rheumatoid arthritis.